Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-303.62	-223.47	-55.37
Graham Fair Price	-53.75	0.65	1.41
PEG	1062.15	0.71	-0.06
Price/Book	146.99	104.58	42.34
Price/Cash Flow	-89.62	-231.51	-122.09
Prices/Earnings	-225.74	-41.97	-12.88
Price/Sales	-58.79	485.69	1178.63
Price/FCF	-89.62	-231.51	-122.09
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	97.76	-0.29	-12.83
Operating Margin	90.63	-2.19	-23.40
ROA	43.04	-0.21	-0.37
ROE	-0.82	-0.62	24.18
ROIC	-0.41	-0.26	38.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.06	0.18	-68.18
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.30	0.63	-51.81
EPS QOQ	-2.11	0.59	-71.97
FCF QOQ	-0.08	0.13	72.22
Revenue QOQ	-0.90	2.99	232.55
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	161.21	448.53	178.23
Days Sales Outstanding (DSO)	814.22	198.27	-75.65
Inventory Turnover	0.56	0.20	-64.06
Debt/Capitalization	0.34	0.46	34.25
Quick Ratio	1.10	0.53	-51.31
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	0.33	0.17	-46.89
Cash	0.15	0.04	-72.01
Capex	< 0.005	< 0.005	-99.32
Free Cash Flow	-0.11	-0.08	30.82
Revenue	0.01	0.04	218.33
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	2.43	1.62	-33.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.40	-1.89	-370.89
Naive Interpretation	Member

06 - Financial Health · Weak

Rating